Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 
 
Litigation Image

Litigation

Post-Grant

Prosecution & Counseling

Fish has a global litigation practice with a proven record of successfully handling high-tech, high-stakes matters. We have a long history of litigating for technology pioneers, from the Wright brothers to today’s innovators in life sciences, electronics, medical devices, and more. Our trial skills are enriched by our broad and deep technical patent expertise – an expertise that sets us apart from general practice firms.

Fish recognizes that the only purpose of litigation is to achieve the client’s specific business objectives. We prepare every case with those business objectives in mind. When we can best serve our clients by resolving disputes short of trial, we do so. We are also uniquely positioned to handle any case that can benefit from understanding and explaining science and technology or presenting expert evidence.

Our attorneys enforce and defend an array of intellectual property claims for clients, ranging from some of the world’s largest corporations to individual inventors and innovators. Surveys show that we handle more patent litigation than does any other firm in the world, in both federal district courts and at the International Trade Commission. We are also a dominant force in commercial litigation—specifically in areas such as product liability/mass torts and trade secrets.

eFISHentTM Litigation

Fish is dedicated to delivering the highest quality legal services and support to our clients. By design, our eFISHent Litigation approach enables us to achieve our clients’ objectives at a price that is an outstanding value – and we do it at all points of litigation. Learn more about our approach to eFISHent Litigation and our innovative eFISHencyTM systems here.

Recent Wins

Fish & Richardson Wins for the Chamberlain Group

May 2018 – Fish & Richardson recently won a permanent injunction, treble damages and attorneys’ fees for the Chamberlain Group (CGI), an industry leader in the garage door industry, following an August 2017 jury verdict finding that Ryobi and Techtronic Industries (TTI) willfully infringed two of CGI’s patents. Read more here.

Fish Wins Federal Circuit Affirmance of Reversal of $200 Million Damages Against Gilead

April 2018 – Fish won a unanimous Federal Circuit opinion today that affirmed its June 2016 post-trial wipe-out of a $200 million jury verdict against client Gilead Sciences, Inc. after proving Merck had forfeited its right to assert its hepatitis C drug patents against Gilead because of litigation and business misconduct constituting “unclean hands.” Read more about this precedential opinion here and here.

Roaring Back From the Largest-Ever Patent Verdict

February 2018 – In late 2016, Gilead Sciences, Inc. and a Fish & Richardson trial team led by Jonathan Singer were hit with a $2.5 billion jury verdict, the largest ever recorded in a U.S. patent infringement case. Read how they turned the tables.


Highlights

Search Fish Team

Search by Letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
No matches
Litigation

Litigation Team

What's Trending in Litigation

Filter by
Fish Litigation Blog
July 6, 2018
The Return of Opinions of Counsel in Patent Cases: How Recent Judicial Decisions Have Made Them Relevant Once More
The Return of Opinions of Counsel in Patent Cases: How Recent Judicial Decisions Have Made Them Relevant Once More
Authors: Daniel Sternberg, Lawrence K. Kolodney
IP Litigation
Federal Circuit
News
June 28, 2018
Fish & Richardson Attorney Ricardo Bonilla Named a 2018 On the Rise – Top 40 Young Lawyer by the ABA
Press Release
Fish Litigation Blog
June 28, 2018
Live from the 9th Annual Summit on Biosimilars
Live from the 9th Annual Summit on Biosimilars
Authors: Jenny Shmuel, Ph.D., Tasha M. Francis, Ph.D.
IP Litigation
Life Sciences
Event
July 19th, 2018 | 1:00 pm EDT
Webinar | Berkheimer v. HP: A Favorable Shift for Software and Medical Methodology Patents?
Webinar | <em>Berkheimer v. HP</em>: A Favorable Shift for Software and Medical Methodology Patents?
Webinar
News
June 26, 2018
Fish & Richardson Principals Betsy Flanagan and Jennifer Huang Named 2018 Up & Coming Attorneys by Minnesota Lawyer; Megan Connolly and Jill Strand Named Unsung Legal Heroes
Press Release
Fish Litigation Blog
June 20, 2018
New Draft Guidance on FDA Meetings, But Nothing Further on Substantive Requirements for Biosimilars and Interchangeables
New Draft Guidance on FDA Meetings, But Nothing Further on Substantive Requirements for Biosimilars and Interchangeables
Authors: Jenny Shmuel, Ph.D., Tasha M. Francis, Ph.D.
IP Litigation
Life Sciences
Fish Litigation Blog
June 19, 2018
Federal Circuit Reviews Factors Defining Printed Publications as Prior Art
Federal Circuit Reviews Factors Defining Printed Publications as Prior Art
Authors: Will Orlady, Ryan Petty
IP Litigation
News
June 18, 2018
Fish Principal Bob Oakes Interviewed Regarding Patent Issues Related to Gene Editing Technology
Media Mention
Fish Litigation Blog
June 15, 2018
Method of Treatment Claims Pass Mayo Test
Method of Treatment Claims Pass <i>Mayo</i> Test
Author: Betsy Flanagan
IP Litigation
Federal Circuit
Life Sciences
News
June 13, 2018
Andrew Kopsidas Quoted in Managing Intellectual Property, "How the New ITC Rules Change Litigation Strategy"
Media Mention
Fish Litigation Blog
June 13, 2018
Fish Obtains First PGR Reversal at Federal Circuit in Altaire Pharmaceuticals, Inc. v. Paragon Bioteck, Inc.
Fish Obtains First PGR Reversal at Federal Circuit in <i>Altaire Pharmaceuticals, Inc. v. Paragon Bioteck, Inc.</i>
Authors: Oliver J. Richards, Ahmed J. Davis, Gwilym J. O. Attwell, Craig Countryman
IP Litigation
Federal Circuit
Life Sciences
Event
July 25th, 2018
World Congress' 15th Annual Summit on Protecting Innovations in the Financial Services Industry
World Congress' 15th Annual Summit on Protecting Innovations in the Financial Services Industry
Speaking Engagement
Sponsorship
load more topics